Published Online
on December 2, 2002

A more recent version of this article appeared on January 1, 2003

This Article Full Text (PDF) All Versions of this Article: 34/1/8    most recent 01.STR.0000044950.15362.A4v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fournier, A. Articles by Andrejak, M. Search for Related Content PubMed PubMed Citation Articles by Fournier, A. Articles by Andrejak, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Kidney Diseases Stroke

Converting Enzyme Inhibitor or AT₁-Receptor Blocker for Decreasing Long-Term Mortality in Patients With Stroke History and Renal Dysfunction?

A. Fournier MD; O. Godefroy MD; R. Oprisiu MD; M. Slama MD; and M. Andrejak MD

Department of Nephrology CHU Hôpital Sud 80054 Amiens Cedex 1 Paris, France

This article has been cited by other articles:

				J. P. Ruiz, L. M. Medina, F. M. Parra, J. M. de la Higuera Torres-Puchol, R. S. MacWalter, S. Y.S. Wong, K. Y.K. Wong, and A. D. Struthers Stroke Prevention: Indapamide, a Forgotten Option? * Response Stroke, September 1, 2003; 34 (9): e156 - e157. [Full Text] [PDF]